1-methyl-3-isobutylxanthine has been researched along with Precancerous Conditions in 1 studies
1-Methyl-3-isobutylxanthine: A potent cyclic nucleotide phosphodiesterase inhibitor; due to this action, the compound increases cyclic AMP and cyclic GMP in tissue and thereby activates CYCLIC NUCLEOTIDE-REGULATED PROTEIN KINASES
3-isobutyl-1-methylxanthine : An oxopurine that is xanthine which is substituted at positions 1 and 3 by methyl and isobutyl groups, respectively.
Precancerous Conditions: Pathological conditions that tend eventually to become malignant.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cortinovis, C | 1 |
| Mayer, D | 1 |
| Bouscarel, B | 1 |
| Paris, H | 1 |
| Murat, JC | 1 |
1 other study available for 1-methyl-3-isobutylxanthine and Precancerous Conditions
| Article | Year |
|---|---|
Study of beta-adrenoceptors and beta-adrenergic responsiveness in cultured "preneoplastic-like" and neoplastic rat hepatocytes.
Topics: 1-Methyl-3-isobutylxanthine; Adrenergic beta-Antagonists; Albuterol; Animals; Atenolol; Binding, Com | 1985 |